The historical trend is about to turn bullish for stocks. The Stock Trader’s Almanac issued a seasonal buy signal for equities, saying investors who sold in May can start to come back to the market now as the calendar nears what are historically the best six months of the year. The six-month period from November through April boasts a stellar track record for equities while, typically, the months from May through October are more lackluster. Take a look at what’s happened with the Dow Jones Industrial Average . Since 1950, the November-April period accounted for the bulk of the benchmark’s…
Author: usaeverydaylife
Democratic presidential nominee and U.S. Vice President Kamala Harris delivers remarks during a campaign event at a fire station, in Redford Charter Township, Michigan U.S., October 4, 2024. Elizabeth Frantz | ReutersVice President Kamala Harris unveiled an “Opportunity Agenda” proposal for Black men Monday, which includes plans to provide 1 million forgivable loans to Black entrepreneurs and new pathways to help Black Americans succeed in the legalized marijuana industry.”This agenda is a further realization of Vice President Harris’ Opportunity Economy,” said former Rep. Cedric Richmond, a Harris campaign co-chair, in a statement. “An economy where people don’t just get by, but get ahead. Where Black men are…
Two weeks ago, Uruguayan tennis player Pablo Cuevas announced his retirement.When it came, tennis fans the world over dipped into their memory banks in admiration of the modern master of the trick shot. With excellent hands and a huge amount of talent, Cuevas could pull off shots from between his legs, no-look winners, drop-shot returns and so much more at will.But like Mansour Bahrami, the trick-shot king to whom he was heir, Cuevas was far more than just a flashy shotmaker. On his day, he could compete with the very best players in tennis. In 2016, he defeated Rafael Nadal…
HSBC has high hopes for the third quarter earnings season and is sure that some stocks will do better than others. The latest quarter’s results kicked off in earnest on Friday following reports from BlackRock , JPMorgan and Wells Fargo . Financial firms from Citigroup to regional banks including PNC Financial Services will post their earnings in coming days, alongside this week’s blockbuster reports from Netflix and Procter & Gamble , among many others. Third-quarter numbers are likely to follow what was a positive second-quarter earnings season. In the three months ended June 30, nearly 79% of companies in the…
A pro-Palestinian protest erupted outside of the New York Stock Exchange on Monday. There was no disruption to trading and none of the protestors appeared to make it to the historic trading floor.NYSE security fences off a perimeter area outside of the exterior of the building on Broad street in lower Manhattan. According to video shared on social media, the group, called Jewish Voice for Peace, broke into that area and protestors were chaining themselves to the security fence and some exterior doors. Some of the protestors were arrested and being carried away in zip ties, the videos showed.The exchange…
This article is part of our Origin Stories series, an inside look at the backstories of the clubs, drivers, and people fueling the sport.Zak Brown never grew up expecting to become one of the most powerful figures in Formula One.He doesn’t come from a racing background, nor does he have a college degree. Motorsport wasn’t even his “first love.” It was baseball. At one point in his career, he was sleeping on an air mattress on the floor of a friend’s sister’s dining room in England, working for £75 a day.Brown, born in Los Angeles, Calif., but considers himself British given how…
Here are the biggest calls on Wall Street on Monday: TD Cowen reiterates Nvidia as buy TD said Nvidia remains a top pick at the firm. “NVIDIA Is Our Team’s Top Pick, the Far and Away Tech Leader in AI.” Mizuho reiterates Advanced Micro Devices as outperform Mizuho says it’s sticking with the stock following its AI day last week. “With AMD gaining server share, a potential PC rebound and upcoming AI product launches, we see a base case PT of $19…” Mizuho reiterates Broadcom as outperform Mizuho raised its price target on the stock to $220 per share from…
A Boeing worker waves a picket sign Tuesday, Sept. 24, 2024, as workers continue to strike outside the company’s factory in Renton, Wash.Lindsey Wasson | APIt’s been just over a month since more than 30,000 Boeing machinists walked off the job after overwhelmingly voting down a tentative contract. Costs and tensions have only risen since then.The strike is adding to pressure on Boeing’s new CEO, Kelly Ortberg, who was brought in over the summer to solve the plane maker’s various troubles. The strike, which S&P Global Ratings estimates costs Boeing more than $1 billion a month, bookends an already difficult…
A view of Singapore’s skyline and Marina Bay.Fraser Hall | The Image Bank | Getty ImagesSingapore’s central bank on Monday left its monetary settings unchanged, as expected, as data showed the economy perked up in the third quarter though analysts are betting on a loosening in policy early next year to guard against external risks.The Monetary Authority of Singapore said it will maintain the prevailing rate of appreciation of its exchange rate-based policy band known as the Nominal Effective Exchange Rate, or S$NEER.The width and the level at which the band is centered would also be maintained, the MAS said.”The risks…
It’s time to buy shares of this under-the-radar injectable delivery and beauty packaging maker with more than 30% upside potential, according to Jefferies. Analyst Daniel Rizzo upgraded shares of Aptargroup to a buy rating, saying that new pharmaceutical delivery products should drive 10% sales growth on a compound annual basis through 2027. ATR YTD mountain Aptargroup, YTD Given solid execution, ATR has risen ~30% YTD (vs the S & P 500’s +22%), but with a strong pipeline of new products such as delivery systems for GLP-1 drugs, for OTC Narcan, and for Neffy (epinephrine nasal spray), we estimate the Pharma…
